Evaluation of plasma Epstein‐Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high‐risk populations in Southern China

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|9|1353-1360

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.9, 2014-05, pp. : 1353-1360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epstein-Barr Virus EBNA-2 Polymorphic Patterns in Nasopharyngeal Carcinoma in Southern China

By  

Intervirology, Vol. 58, Iss. 6, 2016-04 ,pp. : 386-392

Karger

Access to resources Recommend Favorite

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2720-2729

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel Application of Plasma and Cerebrospinal Fluid Level of Epstein Barr Virus DNA in the Diagnosis of Leptomeningeal Metastasis from Nasopharyngeal Carcinoma

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 119-122

Karger

Access to resources Recommend Favorite

Genotypic Analysis of Epstein-Barr Virus Isolates Associated with Nasopharyngeal Carcinoma in Northern China

By  

Intervirology, Vol. 54, Iss. 3, 2010-10 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Pretreatment Epstein-Barr Virus DNA Load and Cumulative Cisplatin Dose Intensity Affect Long-Term Outcome of Nasopharyngeal Carcinoma Treated with Concurrent Chemotherapy: Experience of an Institute in an Endemic Area

By  

Oncology Research and Treatment, Vol. 37, Iss. 3, 2014-02 ,pp. : 88-95

Karger

Access to resources Recommend Favorite